TARS files Form 144 to sell 2,133 shares

TARS files a Form 144 notice to sell 2,133 shares of Common Stock following restricted stock vesting on 03/17/2026.

Accepted by SEC EDGAR 03/18/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TARS files a Form 144 notice to sell 2,133 shares of Common Stock following restricted stock vesting on 03/17/2026.

The filing shows the shares are tied to compensation (restricted stock vesting). The excerpt also reports that Jeffrey Farrow sold 2,111 shares on 03/17/2026. Trading venue is listed as NASDAQ.

Insights

Securities Counsel

Form 144 filed for vested restricted shares; prior small disposition recorded.

The filing lists a proposed sale of 2,133 shares of Common Stock tied to restricted stock vesting dated 03/17/2026. The entry explicitly labels the source as compensation, indicating issuance from employee award vesting.

Separately, the excerpt records a disposition by Jeffrey Farrow of 2,111 shares on 03/17/2026. Cash‑flow treatment and planned sale method are not stated in the provided excerpt; subsequent filings would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TARS shares are listed for sale on the Form 144?

The Form 144 lists 2,133 shares of Common Stock for proposed sale. The filing ties these shares to restricted stock vesting with the vesting date shown as 03/17/2026.

What type of shares and why are they being sold for TARS?

The shares are Common Stock arising from restricted stock vesting, described as compensation. The excerpt indicates the sale relates to vested employee awards dated 03/17/2026.

Did any insider transactions occur recently for TARS?

Yes. The excerpt reports that Jeffrey Farrow sold 2,111 shares of Common Stock on 03/17/2026. That disposition is recorded in the "Securities Sold During The Past 3 Months" section.

Where is TARS stock listed according to the filing?

The filing lists the trading venue as NASDAQ. The excerpt includes a broker address for Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001405253
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tarsus Pharmaceuticals, Inc.
SEC File Number	001-39614
Address of Issuer	15440 LAGUNA CANYON ROAD IRVINE CALIFORNIA 92618
Phone	(949) 409-9820
Name of Person for Whose Account the Securities are To Be Sold	Farrow Jeffrey S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2133	146558.01	42557492	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/17/2026	Restricted Stock Vesting	Issuer			2133	03/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeffrey Farrow 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/17/2026	2111	146534.43

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jeffrey Farrow
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)